Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Hull

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
British Journal of Nursing (Mark Allen Publishing)|April 17, 2013
Clinical trial: physical, psychological and social needs of patientsDiana Hull
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|October 18, 2002
Gene therapy trials: a patient pathwayDiana Hull, Michelle Chester
International Journal of Palliative Nursing|August 4, 2010
Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case studyDiana Hull, Ceri Armstrong
British Journal of Nursing (Mark Allen Publishing)|November 6, 2012
Patient and public involvement to support liver disease researchDiana Hull, Darren Barton, Kathy Guo, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|June 7, 2011
Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task groupKim Edmonds, Diana Hull, Andrea Spencer-Shaw, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 29, 2024
PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UKMohid S Khan, Kathryn Cook, Martin O Weickert, et al.
Journal of Hepatology|September 23, 2015
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitisMatthew J Armstrong, Diana Hull, Kathy Guo, et al.
BMJ Open|November 6, 2013
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trialMatthew J Armstrong, Darren Barton, Piers Gaunt, et al.
Scientific Reports|February 9, 2026
Safety and feasibility of liver maximum capacity assessment in patients undergoing transarterial chemoembolisation for hepatocellular carcinomaGeorge Clarke, Sofi Dhanaraj, Diana Hull, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2013
The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkersPhilip J Johnson, Sarah J Pirrie, Trevor F Cox, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
British Journal of Nursing (Mark Allen Publishing)|April 17, 2013
Clinical trial: physical, psychological and social needs of patientsDiana Hull
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|October 18, 2002
Gene therapy trials: a patient pathwayDiana Hull, Michelle Chester
International Journal of Palliative Nursing|August 4, 2010
Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case studyDiana Hull, Ceri Armstrong
British Journal of Nursing (Mark Allen Publishing)|November 6, 2012
Patient and public involvement to support liver disease researchDiana Hull, Darren Barton, Kathy Guo, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|June 7, 2011
Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: recommendations from a European nursing task groupKim Edmonds, Diana Hull, Andrea Spencer-Shaw, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 29, 2024
PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UKMohid S Khan, Kathryn Cook, Martin O Weickert, et al.
Journal of Hepatology|September 23, 2015
Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitisMatthew J Armstrong, Diana Hull, Kathy Guo, et al.
BMJ Open|November 6, 2013
Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trialMatthew J Armstrong, Darren Barton, Piers Gaunt, et al.
Scientific Reports|February 9, 2026
Safety and feasibility of liver maximum capacity assessment in patients undergoing transarterial chemoembolisation for hepatocellular carcinomaGeorge Clarke, Sofi Dhanaraj, Diana Hull, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2013
The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkersPhilip J Johnson, Sarah J Pirrie, Trevor F Cox, et al.
Pageof 2